Mauna Kea Technologies S.A. (MKEAF) Research

Headquartered in Paris, France, Mauna Kea Technologies S.A. commenced operations in 2000. This company specializes in developing and commercializing medical devices, with a broad market presence spanning Europe, the Middle East, Africa, the Americas, and Asia. A primary focus for Mauna Kea Technologies is creating and distributing instruments designed to enable the real-time detection and visualization of cellular irregularities. These innovative tools are utilized during standard endoscopic examinations of the gastrointestinal and pulmonary systems. Their leading product, Cellvizio, stands as a prime example: it is an advanced confocal miniprobe endomicroscopy system. Cellvizio delivers exceptionally detailed, cellular-level images of tissues to both physicians and scientific researchers.

Market snapshot

Symbol
MKEAF
Price
$0.37
Day change
0.00%
Market cap
$13.3M
P/E ratio
2.50x
52-week range
0.37-0.37
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Chill Brands Group PLC (CHBRF)
  • MakingORG, Inc. (CQCQ)
  • Dignitana AB (publ) (DIZTF)
  • Generation Hemp, Inc. (GENH)
  • HS GovTech Solutions Inc. (HDSLF)
  • IBEX Technologies Inc. (IBXNF)
  • IntelGenx Technologies Corp. (IGXT)
  • ImmuPharma plc (IMMPF)

Open Mauna Kea Technologies S.A. (MKEAF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.